Rockefeller University

New York, New York, United States
Purpose
to fund a study testing the hypothesis that broadly neutralizing antibodies against HIV-1 produced by gene editing can protect against infection
Division
Global Health
Date
AUGUST 2019
Region served
GLOBAL
Committed amount
$2,838,049
Grant topic
Create Novel Biotech Platform Capabilities,
Support Innovative Technology Solutions
Duration (months)
36
Grantee location
New York, New York, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.